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GENETIC DIVERSITY AND ANTIMICROBIAL RESISTANCE OF ENTEROCOCCAL ISOLATES FROM
SOUTHERN REGION OF BRAZIL
Pedro Alves d’AZEVEDO(1), Cícero Armídio Gomes DIAS(1) & Lúcia Martins TEIXEIRA(2)
SUMMARY
In the present study, a total of 455 enterococcal isolates, recovered from patients living in the city of Porto Alegre, State of Rio
Grande do Sul, Brazil, during the period from July 1996 to June 1997, were identified to the species level by conventional
biochemical and microbiological tests, and assayed for their susceptibilities to antimicrobial agents. The genetic diversity of
antimicrobial resistant strains was evaluated by pulsed-field gel electrophoresis (PFGE) analysis of SmaI restricted chromosomal
DNA. The most frequent species was Enterococcus faecalis (92.8%). Other species identified were: E. faecium (2.9%), E. gallinarum
(1.5%), E. avium (1.1%), E. hirae (0.7%), E. casseliflavus (0.4%), E. durans (0.4%) and E. raffinosus (0.2%). The overall prevalence
of isolates with high-level resistance (HLR) to aminoglycosides was 37.8%. HLR to gentamicin was found in 24.8%. No strains
with acquired resistance to vancomycin were found. PFGE analysis showed the predominance of clonal group A, comprising
strains isolated from different clinical specimens obtained from patients in three hospitals. These results suggest intra and inter-
hospital dissemination of one predominant clonal group of E. faecalis isolates with HLR to gentamicin in the hospitals included in
this study.
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INTRODUCTION
Enterococci have become one of the most prominent nosocomial
pathogens in the last few decades14,19. Resistance to several classes of
antimicrobial agents is a remarkable characteristic of enterococcal
isolates increasingly reported worldwide6,16. Bactericidal antimicrobial
activity, necessary for the treatment of enterococcal infections, is usually
obtained by the sinergistic combination of a cell-wall active agent, such
as a β-lactam or a glycopeptide, with an aminoglycoside, such as
gentamicin or streptomycin. However, the efficacy of this antimicrobial
therapy has been threatened by the increasing occurrence of high level
resistance to gentamicin (HLR-Ge) and streptomycin (HLR-St) among
enterococci in several countries7,13,16 including in Brazil1,10,12,18,20.
Different molecular methods have been used to study the
epidemiology and diversity of enterococci isolates expressing
multidrug-resistence, including pulsed-field gel electrophoresis (PFGE)
and polymerase chain reaction (PCR), but PFGE has been considered
the method of choice for typing enterococcal isolates22,23.
The increasing prevalence of high level aminoglycoside resistance
among enterococcal isolates recovered in hospitals in Brazil has been
documented, and the results of molecular studies using PFGE suggested
the presence and spread of two clonal groups1,10,18. The level of
aminoglycoside resistance and the clonal characteristics of strains
isolated in the Southern region of Brazil are still unknow. Considering
the increased occurrence of antimicrobial resistant enterococcal
isolates, the importance of these microorganisms as a cause of
nosocomial infections, and the lack of information about enterococci
isolates in the southern part of Brazil, we decided to evaluate the
phenotypic and genotypic characteristics of a diverse collection of 455
enterococci isolates recovered in the city of Porto Alegre, located in
the state of Rio Grande do Sul (RS), a southern city in Brazil. We (1)
identify the isolates to the species level, (2) evaluate the isolates
susceptibility to antimicrobials usually used for treatment of
enterococcal infections, (3) investigate the genetic diversity of these
isolates using PFGE, and (4) correlate the high level resistance (HLR)
with clonal groups defined by PFGE.
MATERIALS AND METHODS
Bacterial isolates: A total of 455 enterococcal isolates recovered from
patients receiving medical care in five different hospitals located in the
city of Porto Alegre, RS state, Brazil, were collected during the period
from July 1996 to June 1997. These isolates were recovered from different
clinical specimens, Table 1. A total of five reference strains were used as
controls: Enterococcus faecalis ATCC 29212 (susceptible to vancomycin,
streptomycin and gentamicin), Enterococcus faecium SS 1274, E. faecalis
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CL-445 (high-level resistant to gentamicin [HLR-Ge]), E. faecalis SS-
1332 (high-level resistant to gentamicin and streptomycin [HLR-GeSt]
and vancomycin resistant) and E. faecium (high-level resistant to
streptomycin and ampicillin [HLR-St/Ap]). All reference strains were
obtained from the Streptococcus Laboratory of the Centers for Disease
Control and Prevention (CDC), Atlanta, Georgia, USA.
Identification isolates: All 455 strains were tested for their
phenotypic characteristics by conventional biochemical tests as
recommended by FACKLAM & TEIXEIRA3 and FACKLAM et al.4.
For some isolates with atypical phenotypic identification, analysis of
whole-cell protein profiles by sodium dodecyl-sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) was performed to confirm
identification according to TEIXEIRA et al.21.
Antimicrobial susceptibility test: Susceptibility to vancomycin,
and HLR to aminoglycosides were tested by the agar screening method
as recommended by the NCCLS (National Committee for Clinical
Laboratories Standards)17. HLR to ampicillin was tested by using
Mueller- Hinton agar plates containing 16 µg/mL of this drug20.
Resistant strains were confirmed by the E test (AB Biodisk, Solna,
Sweden). Isolates were tested for β-lactamase production by the
chromogenic cephalosporin (nitrocefin) disk method (Becton Dickinson
Diagnostic Systems, Sparks, Maryland, USA).
DNA extraction and restriction fragment analysis by PFGE:
Chromosomal DNA was obtained as described by TEIXEIRA et al.21.
Purified DNA was digested with the restriction enzyme SmaI (Boehringer
Mannheim Corporation, Indianapolis, Ind.) and separated by PFGE in
1.2% agarose gels, using a CHEF-DRIII system (Bio-Rad Laboratories,
Richmond, Calif.). The pulse time was increased from 5 to 35s, over 22
hours at 6V/cm with the temperature of 11 °C and a 120° angle. Analysis
of chromosomal DNA fragmentation profiles was performed by visual
inspection of the photographic register of ethidium bromide stained gels
according to TENOVER et al.22. Computer-assisted comparison of the
PFGE profiles was performed by using the Molecular Analyst
Fingerprinting Plus software package, version 1.12, of the Image Analysis
System (BioRad), and percentages of similarities of the profiles were
estimated with the Dice coefficient and clustered by the unweighted
pair group method with arithmetic averages (UPGMA).
RESULTS AND DISCUSSION
Table 1 shows the distribution of enterococcal species according to
the source of isolation. The most frequent isolation source was urine
(320 isolates; 70.3%), followed by different types of secretions (94
isolates; 20.7%), blood (12 isolates; 2.6%), catheters (11 isolates; 2.4%)
and other miscellaneous sources (18 isolates; 4.0%). The most frequent
species was E. faecalis (92.8%). Other species identified were: E. faecium
(2.9%), E. gallinarum (1.5%), E. avium (1.1%), E. hirae (0.7%), E.
casseliflavus (0.4%), E. durans (0.4%) and E. raffinosus (0.2%).
Results of antimicrobial susceptibility tests are summarized in Table
2. Frequencies of HLR to aminoglycosides were: 24.8% to gentamicin
Table 1
Sources of the 455 enterococcal isolates obtained from patients in five hospitals in the city of Porto Alegre, Brazil, from July 1996 to June 1997
Number of strains of each species
Source E. faecalis E. faecium E. gallinarum E. avium E. hirae E. casseliflavus E. durans E. raffinosus Total
Urine 310  8 0 0  1  0  1 0  320
Secretions  83  2  2 5  2 0  0  0 94
Blood 11  0  0  0  0  0  0 1 12
Catheter  10  0  1  0  0  0  0 0 11
Others  8  3  4  0  0  2  1 0 18
Total 422  13  7 5 3 2 2 1 455
Table 2
Occurrence of high-level resistance to ampicillin, gentamicin and/or streptomycin and resistance to vancomycin among 455 enterococcal isolates obtained from
patients in five hospitals in the city of Porto Alegre, Brazil, from July 1996 to June 1997
Total isolates/ Antimicrobial Agenta
Species total resistant Ap Ge St Vc
 strains (%)  16 µg/mL 500 µg/mL 2000 µg/mL 6 µg/mL
E. faecalis  181/422 (42.9%) 7  107  67  0
E. faecium  13/13 (100%) 6 5  5  0
E. gallinarum  6/7 (85.7%) 0 0  0  6
E. avium 1/5 (20%) 0 1  0  0
E. hirae 0/3 (0%) 0 0  0  0
E. casseliflavus 0/2 (0%) 0 0  0  1
E. durans  0/2 (0%) 0 0  0  0
E. raffinosus 1/1 (100%) 1 0  0  0
Total (%) 202/455 (44.4%) 14 ( 3.1%) 113 (24.8%) 72 (15.8%) 7 (1.5%)
aAp, ampicillin; Ge, gentamicin; St, streptomycin; Vc, vancomycin.
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and 15.8% to streptomycin. Resistance to both gentamicin and
streptomycin was detected in 13 (2.8%) isolates. Fourteen isolates
showed HLR to ampicillin (MIC ≥ 16 µg/mL): seven were identified
as E. faecalis, six as E. faecium and one as E. raffinosus. Intrinsec
resistance to vancomycin (MIC ≥ 6 µg/mL) was observed in six E.
gallinarum and one E. casseliflavus. None of the isolates showed β-
lactamase activity.
A total of 174 E. faecalis isolates presenting HLR to aminoglycosides
were analysed by PFGE, comprising all 107 with HLR-Ge and all 67
with HLR-St. The results indicated that they were distributed in 26 PFGE
patterns clustered at 70% similarity level. One predominant clonal group
was found among the E. faecalis isolates presenting HLR-Ge. This group
(named as clonal group A) was composed by 80 (70.8%) isolates
recovered from patients in three hospitals (Irmandade Santa Casa de
Misericórdia de Porto Alegre, Hospital da Criança Santo Antônio e
Hospital de Clínicas de Porto Alegre [Fig.1]). Such isolates were
distributed among 47 highly related PFGE profiles presenting degrees
of similarity of 82.7% ± 3.1. Profiles composing the clonal group A
were also related to the profile of a strain representative of the
predominant clonal group previously identified among isolates in the
cities of Rio de Janeiro and Niterói, Southeast region of Brazil1,12.
Although studies accomplished in other countries show a great diversity
among isolates presenting HLR-Ge8,15,16,24, our results indicate clonal
dissemination among three hospitals included in this study. Intra and
inter-institution dissemination of this clone in the cities of Porto Alegre
and in Rio de Janeiro/Niterói, would be explained by the persistence of
a strain with characteristics that would allow its survival, as shown by
other investigators5,9. On the other hand, MURRAY et al.15 demonstrated
the occurrence of isolates with indistinguishable profiles, presenting
differences in resistance to aminoglycosides.
The remaining isolates were distributed in 25 different PFGE
patterns, each one composed by one or two isolates, indicating the
large genetic diversity among the isolates that did not belong to the
predominant clonal group. Most of the strains presenting HLR to both
gentamicin and streptomycin (9/13) were included in this PFGE patterns
indicating a higher degree of genetic diversity among isolates with
such a phenotype. The remaining four HLR-GeST isolates belonged
to clonal group A. This observation is in contrast with other studies
performed with isolates from Rio de Janeiro10,18. The profiles of the
isolates with resistance included in group A were similar, reinforcing
the hypothesis of the presence of strains with “properties” that
contributed to their prevalence and dissemination.
Figures 2 and 3 illustrate the genetic diversity among E. faecalis
and E. faecium isolates presenting HLR-St. The absence of a
predominant PFGE clonal group among E. faecalis isolates presenting
HLR-St was in agreement with previous observations with Brazilian
isolates1,10. The high degree of genetic diversity of the E. faecalis isolates
with HLR-St may be indicative of community origin and that infections
caused by these enterococci may be predominantly endogenous. It is
interesting to note that E. faecium isolates also presented a high degree
of genetic diversity, contributing to the hypothesis that sporadic
infections caused by this microorganism are mostly endogenous.
Fig. 1 - PFGE profiles of SmaI-digested chromosomal DNA of HLR-Ge E. faecalis isolates, obtained from patients in five hospitals in the city of Porto Alegre, Brazil. λ lambda phage DNA
markers; lanes 1-10: isolates belonging to different clonal groups (lane 1: PA-190, lane 2: PA-15, lane 3: PA-24, lane 4: PA-57, lane 5: PA-380, lane 6: PA-283, lane 7: PA-418, lane 8: PA-287,
lane 9: PA-264, lane 10: PA-410, lane 11: PA-322); lanes 12-15: isolates belonging to clonal group A (lane 12: PA-109 (ISCMPA), lane 13: PA-190 (ISCMPA), lane 14: PA-175 (HCSA) and
lane 15: PA-382 (HCPA)).
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Fig. 2 - A) PFGE profiles of SmaI-digested chromosomal DNA of HLR-St E. faecalis isolates obtained from patients in five hospitals in the city of Porto Alegre, Brazil. B) Dendrogram
resulting from a computer-assisted analysis of PFGE profiles of HLR-St E. faecalis isolates shown in A.
Fig. 3 - A) PFGE profiles of SmaI-digested chromosomal DNA of E. faecium isolates from patients in five hospitals in the city of Porto Alegre, Brazil. B) Dendrogram resulting from a
computer-assisted analysis of PFGE profiles of E. faecium isolates shown in A.
In summary, the present study describes the phenotypic and
genotypic characteristics of enterococcal isolates circulating in five
hospitals located in the city of Porto Alegre, Brazil, during 1996 to
1997. These data serve as a basis for additional surveillance studies of
infections caused by these microorganisms. The results indicate intra
and inter-hospital dissemination of a predominant clone of E. faecalis
presenting HLR-Ge in the hospitals included in this study.




Diversidade genética e resistência aos antimicrobianos de
amostras de enterococos isoladas na região Sul do Brasil
Foram estudadas 455 amostras de enterococos isolados de pacientes
moradores da cidade de Porto Alegre, Rio Grande do Sul, Brasil, durante
o período de julho 1996 a junho 1997 e foram identificados ao nível de
espécies por testes fisiológicos convencionais e analisados sua
susceptibilidade aos agentes antimicrobianos. A diversidade genética
foi avaliada por eletroforese de campo pulsado (“pulsed-field gel
electrophoresis”, PFGE) com a enzima de restrição SmaI. A espécie
mais freqüente encontrada foi o Enterococcus faecalis (92,8%). As
outras espécies identificadas foram: E. faecium (2,9%), E. gallinarum
(1,5%), E. avium (1,1%), E. hirae (0,7%), E. casseliflavus (0,4%), E.
durans (0,4%) and E. raffinosus (0,2%). A prevalência de amostras
com níveis elevados de resistência (HLR) aos aminoglicosídeos foram
de 37,8%. HLR para gentamicina foi encontrada em 24,8% das
amostras. Nenhuma amostra com resistência adquirida à vancomicina
foi isolada. A análise através de PFGE revelou a predominância do
grupo clonal A, constituído por amostras isoladas de diferentes materiais
clínicos obtidos de pacientes internados em três hospitais. Esses
resultados sugerem a disseminação intra e inter-hospital de um clone
predominante, composto por amostras de E. faecalis apresentando
níveis elevados de resistência a gentamicina, nos hospitais incluídos
neste estudo.
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